Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib following Immunotherapy: A Real World Evidence Study is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIMHD NIH HHS
Grant: K23 MD017217
NCI NIH HHS
Grant: P30 CA015083
National Institutes of Health
Grant: P30CA15083
National Institutes of Health
Grant: 1K23MD017217-01A1
Working to Eliminate Care Disparities in Liver Cancer in Southeast Asian Americans: Transportation and Other Social Determinants of Health.
National Institutes of Health
Grant: 5P30CA015083-32
CORE--MICROARRAY
FWCI
1.20
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals